Holen Sie sich die Stockscreener-App
57.79
0.14%
-0.08
Schlusskurs vom Vortag:
$57.87
Offen:
$58.2
24-Stunden-Volumen:
21,420
Relative Volume:
0.38
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.69%
1M Leistung:
-0.21%
6M Leistung:
+10.73%
1J Leistung:
+45.93%
1-Tages-Spanne:
$57.79
$58.49
1-Wochen-Bereich:
$55.28
$58.49
52-Wochen-Spanne:
$39.21
$60.73
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
State Street Spdr S P Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
57.79 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
366.79 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
745.64 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
749.14 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
289.09 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
717.54 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
BNP Paribas Easy MSCI China Min (CHINUP.XC) interactive stock chart - Yahoo Finance UK
If You Hold This Healthcare ETF, You’re Losing Big - 24/7 Wall St.
Stock Market Today: Dow, S&P 500, Nasdaq Futures Drop After UAE Nuclear Plant Strike— Regeneron Pharma, N - Benzinga
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
IHE: Healthcare Dashboard For May - Seeking Alpha
ETFs Investing in Esperion Therapeutics, Inc. Stocks - TradingView
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
ETFs Investing in Regeneron Pharmaceuticals, Inc. Stocks - TradingView
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
FDA commissioner raises concerns about US pharma lagging behind China in drug development - MSN
ETFs Investing in Zoetis, Inc. Class A Stocks - TradingView
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
State Street SPDR S&P Software & Services ETF (XSW)A Neutral, Suitability-Focused Assessment for Sector InvestorsAnnual Report - newser.com
7 ETFs to Play a Healthcare Rebound - Barron's
Healthcare Is Due for a Rebound. These ETFs Are a Good Way to Buy In. - Barron's
State Street SPDR S&P Pharmaceuticals ETF (XPH) Stock Price, Holdings, Dividend Yield - GuruFocus
Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026 - 24/7 Wall St.
Small Cap Stocks Trading At 52-Week High - Trefis
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Why Is Organon Stock Skyrocketing Monday? - Benzinga
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0610 - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
When the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth Revisiting - 24/7 Wall St.
ETFs Investing in Recursion Pharmaceuticals, Inc. Class A Stocks - TradingView
State Street SPDR S&P Biotech ETF (XBI) – Performance Review, Structural Profile, and Investment Suitability AssessmentFinancial Summary - newser.com
Why Is Amneal Pharmaceuticals Stock Gaining Today? - Sahm
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now - 24/7 Wall St.
XPH ETF | State Street SPDR S&P Pharmaceuticals ETF - GuruFocus
XPH | State Street SPDR S&P Insider Trading - Quiver Quantitative
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - Yahoo Finance
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Database
Stock Market Research, Data and Tools - GuruFocus
Is State Street SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Emerging Markets Dividend ETF (EDIV) a Strong ETF Right Now? - Yahoo Finance
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended December 31, 2025 - marketscreener.com
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
Stock Market Today: Dow, S&P 500 Futures Drop Ahead Of Trump's 'Power Plant Day' Deadline— UnitedHealth - Benzinga
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
The Trader: Biotechs Are a Healthy Growth Bet. Thank M&A and New Drugs. -- Barron's - 富途牛牛
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 24/7 Wall St.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Vanguard Global Government Bond (VGGF.AS) Holdings - Yahoo! Finance Canada
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
No deal yet? Trump readies new tariffs on select drugmakersreport (SPY:NYSEARCA) - Seeking Alpha
Finanzdaten der State Street Spdr S P Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für State Street Spdr S P Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):